Georgy Agaroff

“Maybe it was a little bit of beginner’s luck,” Georgy Egorov tells us, reflecting on his first CFO appointment at a biotech startup. Although the life sciences firm’s blend of knowledge-driven resources and AI placed it at the forefront of drug discovery innovation, Egorov identified a critical vulnerability: the company’s model depended too heavily on…